Barely Significant
← all excerpts

Real-world use of finerenone in diabetic kidney disease: eGFR slope analysis with exploratory data on prior MRA use.

Diabetol Int · 2025 · PMC12532524 · PMID 41111569

1
hedged sentence
closest p
boldest claim

The sentences

Although our analysis did not reach statistical significance, switching to finerenone was associated with a trend toward renal protection, as reflected by the eGFR slope.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.